1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Emergency Contraception in Spain

Emergency Contraception in Spain

  • July 2013
  • -
  • Euromonitor International
  • -
  • 26 pages

According to the latest report published by the Spanish contraception society, SEC, only 14% of Spanish females have used emergency contraception pills in Spain since the government allowed for this product to be bought without a prescription in 2009.

Euromonitor International's Emergency Contraception in Spain report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.


Why buy this report?

* Get a detailed picture of the Emergency Contraception market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


Table Of Contents

Emergency Contraception in Spain
EMERGENCY CONTRACEPTION IN SPAIN

July 2013


LIST OF CONTENTS AND TABLES


Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Emergency Contraception: Value 2009-2012
Table 2 Sales of Emergency Contraception: % Value Growth 2009-2012
Table 3 Emergency Contraception Company Shares by Value 2008-2012
Table 4 Emergency Contraception Brand Shares by Value 2009-2012
Table 5 Forecast Sales of Emergency Contraception: Value 2012-2017
Table 6 Forecast Sales of Emergency Contraception: % Value Growth 2012-2017
Bayer Hispania SA in Consumer Health (spain)
Strategic Direction
Key Facts
Summary 1 Bayer Hispania SA: Key Facts
Company Background
Production
Summary 2 Bayer Hispania SA: Production Statistics 2012
Competitive Positioning
Summary 3 Bayer Hispania SA: Competitive Position 2012
Executive Summary
No Light at the End of the Tunnel
Not Enough Money To Finance Everything
No Changes in the Competitive Environment
Grocery Retailers Benefit From Consumer Demand for Value for Money
Fears Over the Financial Rescue of Spain
Key Trends and Developments
the Spanish Economy Struggles
New Times Require New Laws
Demographics
A Country of Incongruencies
Climate Change Affects Sales
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
Table 8 Life Expectancy at Birth 2007-2012
Market Data
Table 9 Sales of Consumer Health by Category: Value 2007-2012
Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
Table 11 Consumer Health Company Shares 2008-2012
Table 12 Consumer Health Brand Shares 2009-2012
Table 13 Penetration of Private Label by Category 2007-2012
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
Table 16 Forecast Sales of Consumer Health by Category: Value 2012-2017
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Consumer Health Registration and Classification
Advertising
Packaging and Labelling
Distribution
De-listing Or De-reimbursement
Vitamins and Dietary Supplements Registration and Classification
Retail Distribution
Alternative Therapy
Homoeopathic Medicines
Self-medication/self-care and Preventative Medicine
Switches
Summary 4 OTC: Switches 2010-2012
Definitions
Sources
Summary 5 Research Sources












View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Markets

Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Markets

  • $ 6650
  • Industry report
  • March 2017
  • by BCC Research

Use this report to: - Receive information concerning the dynamics and forecasts in the OTC drugs and dietary supplements market - Receive information pertaining to the major regional trends in the global ...

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021 In 2016, the cognitive behavioural therapy for insomnia ...

Global OTC Analgesics Market - Growth, Trends and Forecast (2017 - 2022)

Global OTC Analgesics Market - Growth, Trends and Forecast (2017 - 2022)

  • $ 4250
  • Industry report
  • February 2017
  • by Mordor Intelligence LLP

The global OTC Analgesics market accounted for a market value of USD XX billion in 2015. The market is expected to reach USD XX billion in 2016 and USD XX billion by 2021, growing at a CAGR of xx% during ...

Otc Drugs Markets In China

January 2017 $ 4000

Otc Drugs Companies In China

January 2017 $ 1800

Download Unlimited Documents from Trusted Public Sources

OTC Markets in the US

  • March 2017
    10 pages
  • Pancreatic Canc...  

    Vitamin  

  • United States  

View report >

OTC Industry in the US

  • March 2017
    89 pages
  • OTC  

  • United States  

View report >

OTC Supply in the US

  • March 2017
  • Dietary Supplem...  

  • United States  

View report >

Otc Markets In Europe

23 days ago

Related Market Segments :

OTC

ref:plp2013

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.